Australia markets closed

Nephros, Inc. (NEPH)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
5.25-0.13 (-2.42%)
At close: 03:34PM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
Total revenue
9,973
8,561
10,334
5,687
Cost of revenue
4,397
3,648
4,250
2,484
Gross profit
5,576
4,913
6,084
3,203
Operating expenses
Research development
2,284
2,759
3,090
1,539
Selling general and administrative
7,107
6,466
6,119
4,517
Total operating expenses
9,592
9,417
9,395
6,219
Operating income or loss
-4,016
-4,504
-3,311
-3,016
Interest expense
49
110
195
172
Total other income/expenses net
470
77
102
-234
Income before tax
-3,584
-4,526
-3,404
-3,418
Income tax expense
-
0
-225
-93
Income from continuing operations
-3,584
-4,526
-3,179
-3,325
Net income
-3,824
-4,766
-3,420
-3,402
Net income available to common shareholders
-3,824
-4,766
-3,420
-3,402
Basic EPS
-
-0.52
-0.45
-0.54
Diluted EPS
-
-0.52
-0.45
-0.54
Basic average shares
-
9,079
7,542
6,847
Diluted average shares
-
9,079
7,542
6,847
EBITDA
-
-4,208
-3,009
-3,083